Lupin Limited is a globally recognized pharmaceutical company dedicated to delivering high-quality, affordable healthcare solutions. With a robust presence in over 100 countries, Lupin is committed to addressing the unmet medical needs of patients worldwide. The company specializes in the development, production, and marketing of a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). Lupin's extensive product portfolio spans therapeutic areas such as cardiovascular, anti-infective, diabetology, asthma, and anti-tuberculosis, among others. The company's state-of-the-art research and development facilities are at the forefront of innovation, driving advancements in drug delivery systems and novel formulations. Lupin's commitment to quality and compliance is reflected in its adherence to stringent regulatory standards across its manufacturing processes. As a leader in the pharmaceutical industry, Lupin places a strong emphasis on sustainability and corporate social responsibility. The company actively engages in initiatives that promote health, education, and environmental conservation, reinforcing its dedication to creating a positive impact on society. Through strategic partnerships and collaborations, Lupin continues to expand its global footprint, ensuring access to essential medicines and improving the quality of life for patients around the world.